Lipoprotein oxidation and progression of carotid atherosclerosis

Circulation

Volumn 95, Issue 4, 1997, Pages 840-845

  Salonen, Jukka T ^a   Nyyssönen, Kristiina ^a   Salonen, Riitta ^a   Porkkala Sarataho, Elina ^a   Tuomainen, Tomi Pekka ^a   Diczfalusy, Ulf ^b   Björkhem, Ingemar ^b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

arteriosclerosis; carotid arteries; cholesterol; oxysterols

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ARTERIOSCLEROSIS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; ECHOGRAPHY; EPIDEMIOLOGICAL DATA; HUMAN; HYPERCHOLESTEROLEMIA; LIPID OXIDATION; LIPID PEROXIDATION; LIPOPROTEIN METABOLISM; MALE; MASS SPECTROMETRY; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 0031042559     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.4.840     Document Type: Article

References (13)

1. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;320:915-924.
2. Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet. 1994;344:793-795.
3. Shigenaga MK, Hagen TM, Ames BN. Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci USA. 1994;91:10771-10778.
4. Salonen JT. Epidemiological studies on LDL oxidation, pro- and antioxidants and atherosclerosis. In: Bellomo G, Finardi G, Maggi E, Rice-Evans C, eds. Free Radicals, Lipoprotein Oxidation and Atherosclerosis. London, UK: Richelieu Press; 1995:27-52.
5. Kandutsch AA, Chen HW, Heiniger HJ. Biological activities of some oxygenated sterols. Science. 1978;201:498-501.
6. Hietter H, Bischoff P, Beck JP, Ourisson G, Luu B. Comparative effects of 7β-hydroxycholesterol towards murine lymphomas, lymphoblasts and lymphocytes: selective cytotoxicity and blastogenesis inhibition. Cancer Biochem Biophys. 1986;9:75-83.
7. Carew TE, Schwenke DC, Steinberg D. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks slowing the progression of atherosclerosis in the WHHL rabbit. Proc Natl Acad Sci U S A. 1987;84:7725-7729.
8. Björkhem I, Henriksson-Freyschuss A, Breuer O, Diczafalusy U, Berglund L, Henriksson P. The antioxidant butylated hydroxytoluene protects against atherosclerosis. Arterioscler Thromb. 1991;11:15-22.
9. Freyschuss A, Stiko-Rahm A, Swedenborg J, Henriksson P, Björkhem I, Berglund L, Nilsson J. Antioxidant treatment inhibits the development of intimal thickening after balloon injury of the aorta in hypercholesterolemic rabbits. J Clin Invest. 1993;91:1282-1288.
10. Williams RJ, Motteram JM, Sharp CH, Gallagher PJ. Dietary vitamin E and the attenuation of early lesion development in modified Watanabe rabbits. Atherosclerosis. 1992;94:153-160.
11. Stampfer MJ, Hennekens CH, Manson JE, Coditz GA, Rosner B, Willett WC. Vitamin E consumption and risk of coronary disease in women. N Engl J Med. 1993;328:1444-1449.
12. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willet WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 1993;328:1450-1456.
13. Salonen JT, Nyyssönen K, Korpela H, Tuomilehto J, Seppänen R, Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation. 1992;86:803-811.